High Tower Advisors, LLC Ligand Pharmaceuticals Inc Transaction History
High Tower Advisors, LLC
- $68.3 Billion
- Q3 2024
A detailed history of High Tower Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 5,142 shares of LGND stock, worth $602,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,142
Previous 4,876
5.46%
Holding current value
$602,950
Previous $410,000
25.61%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding LGND
# of Institutions
260Shares Held
18MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$337 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$231 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$118 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$104 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$83 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.98B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...